1. Audience will know prevalence of various HER2 alterations in gyn malignancies and refer to trials appropriately
2. Audience will be able to describe result of TILS trails in cervical cancer.
3. Audience will be able to interpret hormone receptor expression in endometrial cancer
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation